Skip to content

Ivabradin Oxalate

Ivabradin Oxalate

Product Description
CAT No.
ALN-I014002
CAS No.
1086026-42-7
Mol. F.
C27H36N2O5 : C2H2O4
Mol. Wt.
468.6 : 90.0
Stock
Please Inquire
RFQ
Chemical Name : (S)-3-(3-(((3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one oxalate
Smiles : CN(CCCN(CCC1=CC(OC)=C(OC)C=C1C2)C2=O)C[C@@H]3C4=CC(OC)=C(OC)C=C4C3.O=C(O)C(O)=O
Inchi : InChI=1S/C8H12N2OS2/c1-6(11)13-7-4-10(5-7)8-9-2-3-12-8/h7H,2-5H2,1H3

Forced Degradation Studies of Ivabradine and In Silico Toxicology Predictions for Its New Designated Impurities

Piotr Pikul,1 Marzena Jamru00f3giewicz,1,* Joanna Nowakowska,1 Weronika Hewelt-Belka,2,3 and Krzesimir CiuranFront Pharmacol. 2016; 7: 117.

Simultaneous determination of chiral and achiral impurities of ivabradine on a cellulose tris(3-chloro-4-methylphenylcarbamate) chiral column using polar organic mode

Joanna Nowakowska,1 Weronika Hewelt-Belka,2,3 and Krzesimir Ciura – Front Pharmacol. 2016; 7: 117.

Characterization of degradation products of Ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis

ElekFerenczabBélaKovácsabFranciscBodaaMohammadhassanForoughbakhshfasaeicÉva KatalinKelemenbGerg?TóthcZoltán-IstvánSzabó – Journal of Pharmaceutical and Biomedical Analysis Volume 177, 5 January 2020, 112851

Request For Quotation

Related Products